TDGF1 产品
(Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
Categories
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured TDGF1 Categories
TDGF1 抗体
High quality antibodies with extensive validation data.
TDGF1 ELISA试剂盒
Reliable ELISA kits for a wide range of species.
TDGF1 蛋白
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended TDGF1 抗体
- (5)
- (3)
- (2)
Recommended TDGF1 ELISA试剂盒
- (1)
- (1)
- (1)
Recommended TDGF1 蛋白
- (1)
- (1)
Latest Publications for our TDGF1 Products
: "An evaluation of different Cripto-1 antibodies and their variable results." in: Journal of cellular biochemistry, (2019) (PubMed).: "MicroRNA-15b suppresses the growth and invasion of glioma cells through targeted inhibition of cripto-1 expression." in: Molecular medicine reports, Vol. 13, Issue 6, pp. 4897-903, (2016) (PubMed).
: "GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer." in: Cancer research and treatment : official journal of Korean Cancer Association, Vol. 47, Issue 4, pp. 804-12, (2015) (PubMed).
: "Autoregulation and heterogeneity in expression of human Cripto-1." in: PLoS ONE, Vol. 10, Issue 2, pp. e0116748, (2015) (PubMed).
: "Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways." in: Journal of the neurological sciences, Vol. 347, Issue 1-2, pp. 137-42, (2014) (PubMed).
: "Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration." in: The Journal of biological chemistry, Vol. 282, Issue 43, pp. 31643-55, (2007) (PubMed).
: "Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor." in: The Journal of biological chemistry, Vol. 282, Issue 49, pp. 35772-86, (2007) (PubMed).
: "Cripto: a novel target for antibody-based cancer immunotherapy." in: Cancer research, Vol. 64, Issue 11, pp. 4018-23, (2004) (PubMed).
: "Cripto forms a complex with activin and type II activin receptors and can block activin signaling." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Issue 9, pp. 5193-8, (2003) (PubMed).
: "Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells." in: The Journal of cell biology, Vol. 163, Issue 2, pp. 303-14, (2003) (PubMed).
Synonyms and alternative names related to TDGF1
teratocarcinoma-derived growth factor 1 (TDGF1), teratocarcinoma-derived growth factor 1 (Tdgf1), teratocarcinoma-derived growth factor 1 (tdgf1), teratocarcinoma-derived growth factor 1, member 3 L homeolog (tdgf1.3.L), teratocarcinoma-derived growth factor 1, member 1 (tdgf1.1), cb85, CR, CR1, cr1, cr1a, CRGF, CRIPTO, cripto, Cripto-1, cripto-3, frl-1, frl1, tdgf1, TDGF1, tdgf3, wu:fe01d04, xcr1, zgc:109829Protein level used designations for TDGF1
- cripto-1 growth factor
- epidermal growth factor-like cripto protein CR1
- TERATOCARCINOMA-DERIVED GROWTH FACTOR PRECURSOR (EPIDERMAL GROWTH FACTOR-LIKE CRIPTO PROTEIN) (CRIPTO GROWTH FACTOR)
- cripto growth factor
- epidermal growth factor-like Cripto protein
- teratocarcinoma-derived growth factor
- cryptic protein
- one eyed pinhead
- teratocarcinoma-derived growth factor 1
- cripto-1a
- fibroblast growth factor receptor ligand 1
- teratocarcinoma-derived growth factor 3